{"abstract": "The deal will give Merck, the second-largest American drug maker after Pfizer, control of the largest antibiotics company, and deepen its ties with hospitals.", "web_url": "https://dealbook.nytimes.com/2014/12/08/merck-agrees-to-acquire-drug-maker-cubist-for-9-5-billion/", "snippet": "The deal will give Merck, the second-largest American drug maker after Pfizer, control of the largest antibiotics company, and deepen its ties with hospitals.", "lead_paragraph": "Deal making in the health care industry has been booming all year, with medical technology companies and cosmetic drug makers changing hands at rich premiums.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/09/business/Drug/Drug-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/12/09/business/Drug/Drug-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/09/business/Drug/Drug-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/09/business/Drug/Drug-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/09/business/Drug/Drug-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/12/09/business/Drug/Drug-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/09/business/Drug/Drug-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Merck in $8.4 Billion Deal for Cubist, Big Maker of Antibiotics", "kicker": "DealBook", "content_kicker": null, "print_headline": "Merck in Deal for Big Maker of Antibiotics", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Biotechnology and Bioengineering", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Cubist Pharmaceuticals Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 5, "major": "N"}], "pub_date": "2014-12-08T12:53:59+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d7ab937e-c988-5d8e-a3ba-2a9d72be2698", "word_count": 970, "uri": "nyt://article/d7ab937e-c988-5d8e-a3ba-2a9d72be2698"}